Overview

CPL-01 in the Management of Postoperative Pain After Bunionectomy

Status:
Not yet recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
Subjects receive study drug during bunionectomy and are followed for pain and opioid use, with the hypothesis that those who receive CPL-01 will have less pain and less opioid use than either control arm.
Phase:
Phase 3
Details
Lead Sponsor:
Cali Pharmaceuticals LLC
Treatments:
Anesthetics
Anesthetics, Local
Ropivacaine